7VFS image
Deposition Date 2021-09-13
Release Date 2021-11-03
Last Version Date 2025-07-02
Entry Detail
PDB ID:
7VFS
Title:
Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, apo state
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent N-type calcium channel subunit alpha-1B
Gene (Uniprot):CACNA1B
Chain IDs:A
Chain Length:2339
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent calcium channel subunit alpha-2/delta-1
Gene (Uniprot):CACNA2D1
Chain IDs:B
Chain Length:1103
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent L-type calcium channel subunit beta-1
Gene (Uniprot):CACNB1
Chain IDs:C (auth: D)
Chain Length:598
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Closed-state inactivation and pore-blocker modulation mechanisms of human Ca V 2.2.
Cell Rep 37 109931 109931 (2021)
PMID: 34731621 DOI: 10.1016/j.celrep.2021.109931

Abstact

N-type voltage-gated calcium (CaV) channels mediate Ca2+ influx at presynaptic terminals in response to action potentials and play vital roles in synaptogenesis, release of neurotransmitters, and nociceptive transmission. Here, we elucidate a cryo-electron microscopy (cryo-EM) structure of the human CaV2.2 complex in apo, ziconotide-bound, and two CaV2.2-specific pore blockers-bound states. The second voltage-sensing domain (VSD) is captured in a resting-state conformation, trapped by a phosphatidylinositol 4,5-bisphosphate (PIP2) molecule, which is distinct from the other three VSDs of CaV2.2, as well as activated VSDs observed in previous structures of CaV channels. This structure reveals the molecular basis for the unique inactivation process of CaV2.2 channels, in which the intracellular gate formed by S6 helices is closed and a W-helix from the domain II-III linker stabilizes closed-state inactivation. The structures of this inactivated, drug-bound complex lay a solid foundation for developing new state-dependent blockers for treatment of chronic pain.

Legend

Protein

Chemical

Disease

Primary Citation of related structures